{"id":1787,"date":"2013-06-20T00:00:00","date_gmt":"2013-06-20T00:00:00","guid":{"rendered":"http:\/\/www.neurodegenerationresearch.eu\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/"},"modified":"2014-09-22T09:13:52","modified_gmt":"2014-09-22T09:13:52","slug":"first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/","title":{"rendered":"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement"},"content":{"rendered":"<p><strong>Interferon-Beta Aids Balance and Movement in Mice With Spinocerebellar Ataxia 7 <\/strong><\/p>\n<p>The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal, neurodegenerative&amp;nbsp;diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms.  <\/p>\n<p>Researchers in France and the US believe that their results show that a clinical trial in humans is merited. <\/p>\n<p>More information at the link below:<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Interferon-Beta Aids Balance and Movement in Mice With Spinocerebellar Ataxia [&hellip;]<\/p>\n<a href=\"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/\">View Post<\/a>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-1787","post","type-post","status-publish","format-standard","hentry","category-research-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement - JPND Neurodegenerative Disease Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement - JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"og:description\" content=\"Interferon-Beta Aids Balance and Movement in Mice With Spinocerebellar Ataxia [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/\" \/>\n<meta property=\"og:site_name\" content=\"JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-20T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-09-22T09:13:52+00:00\" \/>\n<meta name=\"author\" content=\"jpnd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:site\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"jpnd\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/\"},\"author\":{\"name\":\"jpnd\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\"},\"headline\":\"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement\",\"datePublished\":\"2013-06-20T00:00:00+00:00\",\"dateModified\":\"2014-09-22T09:13:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/\"},\"wordCount\":89,\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"articleSection\":[\"Research News (General)\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/\",\"name\":\"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement - JPND Neurodegenerative Disease Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\"},\"datePublished\":\"2013-06-20T00:00:00+00:00\",\"dateModified\":\"2014-09-22T09:13:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/2013\\\/06\\\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"name\":\"JPND Neurodegenerative Disease Research\",\"description\":\"Neurodegenerative Disease Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\",\"name\":\"JPND\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"width\":248,\"height\":129,\"caption\":\"JPND\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/JPNDeurope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\",\"name\":\"jpnd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"caption\":\"jpnd\"},\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/it\\\/author\\\/jpnd\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement - JPND Neurodegenerative Disease Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/","og_locale":"it_IT","og_type":"article","og_title":"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement - JPND Neurodegenerative Disease Research","og_description":"Interferon-Beta Aids Balance and Movement in Mice With Spinocerebellar Ataxia [&hellip;]","og_url":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/","og_site_name":"JPND Neurodegenerative Disease Research","article_published_time":"2013-06-20T00:00:00+00:00","article_modified_time":"2014-09-22T09:13:52+00:00","author":"jpnd","twitter_card":"summary_large_image","twitter_creator":"@JPNDeurope","twitter_site":"@JPNDeurope","twitter_misc":{"Scritto da":"jpnd"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/#article","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/"},"author":{"name":"jpnd","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a"},"headline":"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement","datePublished":"2013-06-20T00:00:00+00:00","dateModified":"2014-09-22T09:13:52+00:00","mainEntityOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/"},"wordCount":89,"publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"articleSection":["Research News (General)"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/","url":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/","name":"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement - JPND Neurodegenerative Disease Research","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/#website"},"datePublished":"2013-06-20T00:00:00+00:00","dateModified":"2014-09-22T09:13:52+00:00","breadcrumb":{"@id":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/neurodegenerationresearch.eu\/it\/2013\/06\/first-in-vivo-study-of-the-treatment-for-sca7-shows-significant-physical-improvement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurodegenerationresearch.eu\/"},{"@type":"ListItem","position":2,"name":"First in Vivo Study of the Treatment for SCA7 Shows Significant Physical Improvement"}]},{"@type":"WebSite","@id":"https:\/\/neurodegenerationresearch.eu\/#website","url":"https:\/\/neurodegenerationresearch.eu\/","name":"JPND Neurodegenerative Disease Research","description":"Neurodegenerative Disease Research","publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurodegenerationresearch.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/neurodegenerationresearch.eu\/#organization","name":"JPND","url":"https:\/\/neurodegenerationresearch.eu\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","contentUrl":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","width":248,"height":129,"caption":"JPND"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/JPNDeurope"]},{"@type":"Person","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a","name":"jpnd","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","caption":"jpnd"},"url":"https:\/\/neurodegenerationresearch.eu\/it\/author\/jpnd\/"}]}},"_links":{"self":[{"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/posts\/1787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/comments?post=1787"}],"version-history":[{"count":0,"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/posts\/1787\/revisions"}],"wp:attachment":[{"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/media?parent=1787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/categories?post=1787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/it\/wp-json\/wp\/v2\/tags?post=1787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}